AICDA and B-cell non-Hodgkin lymphoma: Since AID overexpression has been associated with multiple human cancers (29), particularly B-cell lymphomas (69, 70), elucidation of the Rem-mediated mechanism targeting AID for degradation may be useful for treatment of both human tumors (29, 69) and infectious diseases.